Stanford Neuro-Immuno-Oncology Program

Program Overview

Cancer cellular therapy is emerging as a promising treatment for aggressive cancers of the central nervous system (CNS). The Neuro-Immuno-Oncology (NIO) Program engages clinicians and scientists across Stanford’s pediatric and adult hospitals to provide specialized, comprehensive clinical care to children and adults receiving CAR T cell therapy for CNS cancers and patients with other forms of cancer experiencing neurological complications of immunotherapies. Members of the clinical team with expertise in neurology, oncology, neuro-oncology, neurocritical care, neurosurgery, neurohospitalist medicine, and psycho-oncology work closely to care for patients. Together with teams studying cutting edge neuroscience, manufacturing cell and gene therapies, and conducting correlative science, the Neuro-Immuno-Oncology Program works in collaboration with the Stanford Center for Cancer Cell Therapy to advance the clinical application and scientific understanding of immuno-oncological therapies for CNS malignancies.   

The NIO program sponsors an innovative fellowship training opportunity to advance training and development of clinical skills in neuro-immuno-oncology.